Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
J&J Snack Foods
JJSF
$1.45B
| $2.85M | ﹤0.01% |
25,091
-17,393
| -41% | -$2.11M |
2024 Q4
2 quarters
|
|
2802
Dimensional US Large Cap Value ETF
DFLV
$6.94B
| $2.83M | ﹤0.01% |
91,193
-2,895
| -3% | -$85.7K |
2024 Q4
2 quarters
|
|
2803
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$127M
| $2.82M | ﹤0.01% |
52,499
+34,384
| +190% | +$1.72M |
2024 Q4
2 quarters
|
|
|
HTBK
2804
DELISTED
Heritage Commerce
HTBK
| $2.82M | ﹤0.01% |
284,228
+44,569
| +19% | +$409K |
2024 Q4
2 quarters
|
|
2805
Avis
CAR
$3.75B
| $2.82M | ﹤0.01% |
+16,678
| New | +$1.8M |
2025 Q2
0 quarters
|
|
2806
Dana Inc
DAN
$2.97B
| $2.81M | ﹤0.01% |
163,999
-11,191
| -6% | -$167K |
2024 Q4
2 quarters
|
|
2807
Aramark
ARMK
$14.4B
| $2.81M | ﹤0.01% |
67,100
-45,343
| -40% | -$1.68M |
2024 Q4
2 quarters
|
|
2808
Prudential
PUK
$30.5B
| $2.81M | ﹤0.01% |
112,125
+3,952
| +4% | +$88.4K |
2024 Q4
2 quarters
|
|
2809
Heritage Insurance Holdings
HRTG
$1.01B
| $2.8M | ﹤0.01% |
112,403
+20,186
| +22% | +$431K |
2024 Q4
2 quarters
|
|
2810
Intellia Therapeutics
NTLA
$1.7B
| $2.8M | ﹤0.01% |
298,711
+49,476
| +20% | +$406K |
2024 Q4
2 quarters
|
|
2811
AltShares Merger Arbitrage ETF
ARB
$101M
| $2.8M | ﹤0.01% |
+98,293
| New | +$2.77M |
2025 Q2
0 quarters
|
|
2812
Edgewell Personal Care
EPC
$1.23B
| $2.78M | ﹤0.01% |
118,831
-101,941
| -46% | -$2.83M |
2024 Q4
2 quarters
|
|
2813
iShares Genomics Immunology and Healthcare ETF
IDNA
$285M
| $2.78M | ﹤0.01% |
135,555
+10,314
| +8% | +$208K |
2024 Q4
2 quarters
|
|
2814
Merchants Bancorp
MBIN
$2.27B
| $2.77M | ﹤0.01% |
83,911
+27,397
| +48% | +$887K |
2024 Q4
2 quarters
|
|
2815
Innovator US Equity Buffer ETF March
BMAR
$204M
| $2.77M | ﹤0.01% |
56,532
+5,308
| +10% | +$245K |
2024 Q4
2 quarters
|
|
|
HBI
2816
DELISTED
Hanesbrands
HBI
| $2.77M | ﹤0.01% |
604,882
-42,186
| -7% | -$204K |
2024 Q4
2 quarters
|
|
2817
Vicor
VICR
$14.2B
| $2.77M | ﹤0.01% |
61,034
+21,838
| +56% | +$976K |
2024 Q4
2 quarters
|
|
2818
SandRidge Energy
SD
$503M
| $2.76M | ﹤0.01% |
255,313
+89,694
| +54% | +$914K |
2024 Q4
2 quarters
|
|
2819
Highwoods Properties
HIW
$3.21B
| $2.76M | ﹤0.01% |
88,850
-107,001
| -55% | -$3.15M |
2024 Q4
2 quarters
|
|
2820
First Trust Exchange-Traded Fund VI First Trust S&P International Dividend Aristocrats ETF
FID
$165M
| $2.76M | ﹤0.01% |
143,368
-89,144
| -38% | -$1.63M |
2024 Q4
2 quarters
|
|
2821
FT Vest US Equity Deep Buffer ETF December
DDEC
$440M
| $2.75M | ﹤0.01% |
65,793
-88,548
| -57% | -$3.53M |
2024 Q4
2 quarters
|
|
2822
Invesco BulletShares 2030 Municipal Bond ETF
BSMU
$276M
| $2.74M | ﹤0.01% |
127,237
-59,848
| -32% | -$1.28M |
2024 Q4
2 quarters
|
|
2823
Capital Group Short Duration Municipal Income ETF
CGSM
$1.59B
| $2.74M | ﹤0.01% |
104,881
+66,933
| +176% | +$1.74M |
2024 Q4
2 quarters
|
|
2824
First Trust Dow Jones Select MicroCap Index Fund
FDM
$259M
| $2.73M | ﹤0.01% |
38,124
+713
| +2% | +$46.1K |
2024 Q4
2 quarters
|
|
|
HIO
2825
Western Asset High Income Opportunity Fund
HIO
$311M
| $2.73M | ﹤0.01% |
686,164
-82,463
| -11% | -$317K |
2024 Q4
2 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.